Clinical Trial Update: Cladribine Tablets After Treatment With Natalizumab (CLADRINA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cladribine tablets after natalizumab therapy in multiple sclerosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)
• Natalizumab (natalizumab)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Multiple Sclerosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING